InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Per Wold-Olsen. Officer active across 1 company, notably Oncopeptides AB. In total, 2 disclosures have been logged. History available since 9 June 2026. The latest transaction was filed on 9 June 2026 (Purchase). Regulator: FIN-FSA. The full history is free.
2 of 2 declarations